Immunotherapy Combined With Radiation Therapy for Genitourinary Malignancies

Immunotherapy drugs have recently been approved by the Food and Drug Administration for the treatment of several genitourinary malignancies, including bladder cancer, renal cancer, and prostate cancer. Preclinical data and early clinical trial results suggest that immune checkpoint inhibitors can ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Ukleja, Jacob, Kusaka, Erika, Miyamoto, David T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141854/
https://www.ncbi.nlm.nih.gov/pubmed/34041029
http://dx.doi.org/10.3389/fonc.2021.663852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141854/
https://www.ncbi.nlm.nih.gov/pubmed/34041029
http://dx.doi.org/10.3389/fonc.2021.663852

Ejemplares similares